Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fiscal third quarter ended April 30, 2013. Among the quarter’s highlights:
•Sequential revenues growth, gross margin improvement and reduced operating loss.
•Following storm-delayed inspection, new diagnostic assays now available to drive revenue growth at Clinical Labs.
Help employers find you! Check out all the jobs and post your resume.
Enzo Biochem Inc. (NYSE:ENZ) today reported results for the fiscal third quarter ended April 30, 2013. Among the quarter’s highlights:
•Sequential revenues growth, gross margin improvement and reduced operating loss.
•Following storm-delayed inspection, new diagnostic assays now available to drive revenue growth at Clinical Labs.
Help employers find you! Check out all the jobs and post your resume.
